Back to Search Start Over

Upregulation of TUBG1 expression promotes hepatocellular carcinoma development.

Authors :
Wang ZJ
Dai ZZ
Hu MZ
Liu JN
Liang H
Shen MM
Zhu SJ
Sheng HJ
Gao J
Huang AL
Tang KF
Source :
Medical oncology (Northwood, London, England) [Med Oncol] 2023 Feb 15; Vol. 40 (3), pp. 96. Date of Electronic Publication: 2023 Feb 15.
Publication Year :
2023

Abstract

Tubulin γ-1 (TUBG1) is a highly conserved component of the centrosome and its deregulation is involved in the development of several types of cancer. However, the role of TUBG1 in hepatocellular carcinoma (HCC) remains unclear. In this study, we found that TUBG1 was upregulated in human HCC cells and tissues and that TUBG1 upregulation was associated with promoter hypomethylation in HCC tissues. TUBG1 knockdown suppressed the proliferation, invasion, and migration of HCC cells. While TUBG1 expression was positively correlated with CD4 + memory T lymphocyte infiltration, it was negatively correlated with CD4 + regulatory T-cell infiltration in human HCC tissues. Furthermore, TUBG1 expression was positively correlated with the expression of genes involved in cell division. Noticeably, high expression of TUBG1 was associated with poor prognosis in patients with HCC. Overall, our findings revealed that TUBG1 promotes hepatocarcinogenesis by increasing proliferation, invasion, and migration of HCC cells and may regulate T lymphocyte infiltration. The current findings provide important insights into TUBG1 regulation in HCC, which could provide new therapeutic targets for hepatocarcinoma which has a very high incidence and mortality rate worldwide.<br /> (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)

Details

Language :
English
ISSN :
1559-131X
Volume :
40
Issue :
3
Database :
MEDLINE
Journal :
Medical oncology (Northwood, London, England)
Publication Type :
Academic Journal
Accession number :
36792863
Full Text :
https://doi.org/10.1007/s12032-023-01966-2